Approval_Correspondence_for_STUDY00021962

APPROVAL
April 14, 2022
Annice Kim
919-5418702, x28702
akim@rti.org
Dear Annice Kim:
On 4/14/2022, the IRB reviewed the following submission:
Type of Review: Initial Study
Title: Testing Message Evaluation Measures Using Youthfocused Vaping Prevention Messages
Investigator: Annice Kim
IRB ID: STUDY00021962
Funding Source: FDA CFSAN
Customer/Client Name: FDA CFSAN
Project/Proposal Number: 0214634.033.000.001
Contract/Grant Number: HHSF223201510002B
IND, IDE, or HDE: None
The IRB approved the study on 4/14/2022. Any changes to the approved study protcol or
documents must be submitted to the IRB as a modification for review and approval prior
to implementation. Within 30 days of study completion, you should request to close the
study in IRB Express. You can submit a modification or study closure by navigating to
the active study and clicking Create Modification / CR.
In conducting this protocol, you are required to follow the requirements listed in the
Investigator Manual (HRP-103), which can be found by navigating to the IRB Library
within the IRB system.
Sincerely,
The RTI Office of Research Protection

Page 1 of 1